CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure. |
Corindus Vascular Robotics, Inc. is furnishing as Exhibit 99.1 to
this Current Report on Form 8-K an investor presentation which
will be used, in whole or in part, and subject to modification,
on March 8, 2017 and at subsequent meetings with investors or
analysts.
The information in this Current Report on Form 8-K (including the
exhibit) is being furnished to Item 7.01 of Form 8-K and shall
not be deemed to be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section, nor will any of such
information or exhibits be deemed incorporated by reference into
any filing under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, except as expressly
set forth by specific reference in such filing.
| Item 9.01 | Financial Statements and Exhibits |
(d)Exhibits.
| Exhibit Number | Description | |
| 99.1 |
Corindus Vascular Robotics, Inc. investor presentation dated March 2017. |
About CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS)
Corindus Vascular Robotics, Inc. designs, manufactures and sells precision vascular robotic-assisted systems for use in interventional vascular procedures (the CorPath System). The Company operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The Company’s product, the CorPath 200 System, is a vascular robotic system, which is engaged in stent placement in percutaneous coronary intervention (PCI) procedures. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. At the bedside, the CorPath System’s robotic drive and sterile, single-use cassette (CorPath Cassette) translate the physician’s commands into movements and manipulations of the coronary stents and catheters. CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Recent Trading Information
CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) closed its last trading session down -0.18 at 1.01 with 1,376,026 shares trading hands.
